Richard T. Moxley

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial”.

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial

The Lancet Neurology(2023)10.1016/s1474-4422(23)00001-7

N/A

1.7DataRank · unranked

60 citations

Richard T. Moxley, Katy Eichinger, Chad Heatwole, Laurence Mignon, W. David Arnold +22 more

Confirmation of the Type 2 Myotonic Dystrophy (CCTG)n Expansion Mutation in Patients with Proximal Myotonic Myopathy/Proximal Myotonic Dystrophy of Different European Origins: A Single Shared Haplotype Indicates an Ancestral Founder Effect

UNC Libraries(2020)10.17615/gzep-km85

N/A

0DataRank · unranked

9 citations

Bjarne Udd, Richard T. Moxley, Fred A. Wright, B. Eymard, Armand Bottani +18 more